Meticulous Research®—a leading global market research company, published a research report titled, ‘Mice Model Market By Mice Type (Inbred, Hybrid), Services (Breeding, Cryopreservation, Quarantine), Technology (CRISPR, Nuclear Transfer), Application (Oncology, Cardiology, Neuro), End User (Research, Academia, Pharmaceutical) - Global Forecast to 2030.’
According to this latest publication from Meticulous Research®, the mice model market is projected to reach $2.48 billion by 2030, at a CAGR of 6.5% from 2023 to 2030. The growth of this market is driven by the advantages of mice as an animal model for studying human diseases, the rising prevalence of cancer, the increasing number of grants for research studies, and the rising demand for personalized medicine. In addition, the technological advancements & innovations in mice models are expected to provide significant growth opportunities for this market.
However, ethical concerns and regulatory restrictions are expected to restrain the growth of this market to a certain extent. In addition, the lack of skilled personnel for animal studies and the high cost of mice models are the major challenges to market growth.
The key players operating in the mice model market are Charles River Laboratories International, Inc. (U.S.), The Jackson Laboratory (U.S.), Laboratory Corporation of America Holdings (U.S.), Horizon Discovery Group plc (U.K.), Trans Genic Inc. (Japan), GenOway S.A. (France), Taconic Biosciences, Inc.(U.S.), Envigo Ltd (U.S.), Janvier Labs (France), ingenious targeting laboratory (U.S.), Harbour Antibodies B.V. (China) (Subsidiary of HBM Holdings), Crescendo Biologics Ltd. (U.K.), Deltagen Inc. (U.S.), and ImmunoGenes Kft. (Hungary).
Mice Model Market: Future Outlook
The mice model market is segmented by mice type, services, technology, mode, application, end user, and geography. The study also evaluates industry competitors and analyzes the country and regional-level markets.
Based on mice type, in 2023, the inbred mice segment is expected to account for the largest share of the mice model market. The large market share of this segment is attributed to the high demand for inbred mice due to their unique genetic composition and their ability to generate consistent and reliable experimental results.
Based on service, in 2023, the breeding segment is expected to account for the largest share of the mice model market. The large market share of this segment is attributed to the increased demand for breeding services for producing customized mice models for various research applications such as oncological studies and cardiovascular disease studies.
Based on technology, in 2023, the CRISPR/CAS9 segment is expected to account for the largest share of the mice model market. The large market share of this segment is attributed to the efficiency of the technology to produce genetically modified mice in a cost-effective manner and the advantages of the technology, such as high precision and faster method for genome editing.
Based on application, in 2023, the oncology studies segment is expected to account for the largest share of the mice model market. The large market share of this segment is attributed to the growing demand for targeted cancer therapies, increased research funding for cancer research, and the high prevalence of cancer globally.
Based on end user, in 2023, the pharmaceutical & biotechnology companies segment is expected to account for the largest share of the mice model market. The large market share of this segment is attributed to large investments by the pharmaceutical & biotechnology companies in drug development, high pharmaceutical R&D expenditure, and rising demand for the rapid development of new drugs.
This research report analyzes the market across major regions and provides a comprehensive analysis of North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, India, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and the Middle East & Africa. In 2023, North America is expected to account for the largest share of the mice model market, followed by Europe and Asia-Pacific. North America’s major market share is attributed to the advanced R&D infrastructure in the region, the presence of major pharmaceutical & biotechnology companies, and high R&D funding by the government.
Download Sample Report Here:https://www.meticulousresearch.com/download-sample-report/cp_id=4151
Key questions answered in the report:
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Connect with us on Twitter- https://twitter.com/MeticulousR123
Dental Practice Management Software Market Worth $ 3.11 Billion by 2029Read More